Enterosgel extracaps capsules of 0.32 g No. 14 (7x2)

Storage

active substance: polymethylsiloxane xerogel;

1 capsule contains polymethylsiloxane xerogel 0.32 g;

excipients: gelatin, titanium dioxide (E 171).

Medicinal form

Capsules for oral use.

Main physicochemical properties: hard gelatin capsules, white body and cap. The contents of the capsules are white or almost white, odorless powder.

Pharmacotherapeutic group

Enterosorbents. ATX code A07V S

Pharmacological properties

Pharmacodynamics.

When used internally, it has a detoxifying effect. The drug effectively adsorbs from the contents of the intestines and blood (through the membranes of the capillaries of the villi of the intestinal mucosa) medium-molecular toxic substances, products of incomplete metabolism, promotes the removal of incorporated radionuclides. Enterosgel ExtraCaps eliminates the manifestations of toxicosis, improves the function of intestines, liver, kidneys, normalizes blood and urine indicators. As an effective detoxifier, Enterosgel ExtraCaps helps increase immunity.

Pharmacokinetics.

The drug envelops the mucous membrane of the stomach and intestines, protects it from erosive processes. It is not absorbed from the intestines.

Indication

As part of complex detoxification therapy for chronic renal failure caused by pyelonephritis, polycystic kidney disease, nephrolithiasis; with toxic hepatitis, viral hepatitis A and B, hepatocholecystitis, liver cirrhosis and cholestasis of various etiologies, gastritis with reduced acidity, enterocolitis, colitis, diarrhea; with alcohol and drug poisoning; allergic reactions, skin diseases (diatheses, neurodermatitis); with burn intoxication; purulent-septic processes accompanied by intoxication; toxicosis of pregnant women in the first half of pregnancy; in complex therapy of intestinal dysbacteriosis.

Contraindication

Acute intestinal obstruction.

Individual intolerance to the components of the drug.

Interaction with other medicinal products and other forms of interaction

Provided that the method of application is followed (Enterosgel ExtraCaps and medicinal products are taken separately), the drug can be used in complex therapy with other medicinal and prophylactic agents, including bacterial preparations (bifidum, lactobacilli), phytopreparations, adaptogens, immunomodulators. Simultaneous use with drugs belonging to the class of bile acid sequestrants, such as cholestyramine, is not recommended due to the increased likelihood of constipation.

The drug should not be used together with silver drugs.

Features of use

The drug should be taken in accordance with the recommendations outlined in this manual.

Use during pregnancy or breastfeeding.

The drug is used during pregnancy or breastfeeding. Use should be limited to pregnant women who are prone to constipation.

The ability to influence the speed of reaction when driving vehicles or other mechanisms.

Does not affect.

Method of application and dosage

Use internally 1-2 capsules 2-3 times a day 1.5-2 hours before or 2 hours after meals or taking medicines, drinking a sufficient amount of water.

For adults and children over 14 years of age, a single dose of the drug is 1-2 capsules, daily – 6 capsules.

For children aged 6 to 14 years, a single dose is 1 capsule, a daily dose is 3 capsules.

The course of treatment is from 7 to 14 days.

In severe forms of the disease, a double single dose is used for the first 3 days, and in the chronic course of the disease (chronic kidney failure, cirrhosis of the liver), longer use of the drug is possible.

Children.

The drug can be used by children aged 6 years and older. To facilitate swallowing, you can open the capsule (single dose) and mix it with a small amount of liquid before use.

Overdose

Exceeding the maximum single doses does not cause adverse reactions.

Side effects

Short-term constipation is possible at the first doses of the drug. To prevent it for people prone to constipation, in the first two days of using the drug, a cleansing enema at night or taking laxatives (lactulose, sodium picosulfate) is recommended.

Manifestations of individual intolerance to the components of the drug are possible.

Expiration date

3 years.

Storage conditions

In the original packaging at a temperature not higher than 25 oC in a place inaccessible to children.

Packaging

7 capsules in a blister. 1, 2 or 4 blisters are placed in a cardboard box.

Leave category

Without a prescription.

Producer

PJSC KREOMA-PHARM.

Address

03680, Ukraine, Kyiv, str. Radishcheva, 3.

The applicant

PJSC KREOMA-PHARM.

The location of the applicant and his address of the place of business.

03680, Ukraine, Kyiv, str. Radishcheva, 3.